Tudor Investment Corp’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-14,954
| Closed | -$74.9K | – | 1505 |
|
2024
Q1 | $74.9K | Buy |
+14,954
| New | +$74.9K | ﹤0.01% | 1378 |
|
2023
Q4 | – | Sell |
-13,533
| Closed | -$105K | – | 1474 |
|
2023
Q3 | $105K | Buy |
+13,533
| New | +$105K | ﹤0.01% | 1384 |
|
2023
Q2 | – | Sell |
-105,952
| Closed | -$1.16M | – | 1532 |
|
2023
Q1 | $1.16M | Buy |
105,952
+64,113
| +153% | +$703K | 0.02% | 848 |
|
2022
Q4 | $181K | Buy |
+41,839
| New | +$181K | ﹤0.01% | 1379 |
|
2022
Q3 | – | Sell |
-62,369
| Closed | -$627K | – | 1575 |
|
2022
Q2 | $627K | Buy |
+62,369
| New | +$627K | 0.02% | 992 |
|
2022
Q1 | – | Sell |
-31,176
| Closed | -$713K | – | 1529 |
|
2021
Q4 | $713K | Buy |
31,176
+15,176
| +95% | +$347K | 0.01% | 1033 |
|
2021
Q3 | $354K | Buy |
+16,000
| New | +$354K | 0.01% | 1255 |
|